CROSS COUNTRY HEALTHCARE INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cross Country Healthcare Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Cross Country Healthcare Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $2.56M, a 80.1% decline year-over-year.
  • Cross Country Healthcare Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$1.77M, a 102% decline year-over-year.
  • Cross Country Healthcare Inc annual Net Income (Loss) Attributable to Parent for 2023 was $72.6M, a 60.9% decline from 2022.
  • Cross Country Healthcare Inc annual Net Income (Loss) Attributable to Parent for 2022 was $186M, a 40.9% increase from 2021.
  • Cross Country Healthcare Inc annual Net Income (Loss) Attributable to Parent for 2021 was $132M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.77M $2.56M -$10.3M -80.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $8.49M -$16.1M -$37.4M -175% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $45.9M $2.69M -$26.7M -90.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $72.6M $9.04M -$29.8M -76.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $102M $12.8M -$22M -63.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $124M $21.3M -$31.5M -59.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $156M $29.4M -$32.5M -52.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $188M $38.8M -$38.8M -50% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $227M $34.8M +$11.4M +48.5% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-23
Q2 2022 $216M $52.9M +$41.3M +358% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-23
Q1 2022 $175M $62M +$42.5M +219% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-23
Q4 2021 $132M $77.6M +$73M +1582% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $59M $23.4M +$24.8M Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 $34.3M $11.5M +$25.7M Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 $8.58M $19.4M +$21.5M Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 -$13M $4.61M +$5.76M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$18.7M -$1.33M +$1.79M +57.4% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-28
Q2 2020 -$20.5M -$14.2M +$37.5M +72.6% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-28
Q1 2020 -$58M -$2.09M -$322K -18.2% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-28
Q4 2019 -$57.7M -$1.14M +$18.5M +94.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$76.3M -$3.13M -$2.69M -609% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$73.6M -$51.7M -$53.2M -3458% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$20.4M -$1.77M -$3.41M -208% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$17M -$19.7M -$47.6M -170% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $30.7M -$441K -$7.16M -107% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-05
Q2 2018 $37.9M $1.54M -$3.31M -68.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 $41.2M $1.64M +$3.65M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 $37.5M $28M +$35.8M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 $1.68M $6.72M -$7.34M -52.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 $9.02M $4.85M +$22.1M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$13.1M -$2.01M -$21M -111% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 $7.97M -$7.88M -$1.79M -29.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-02
Q3 2016 $9.75M $14.1M +$9.06M +181% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-02
Q2 2016 $696K -$17.2M -$19.8M -770% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-02
Q1 2016 $20.5M $19M +$16.1M +548% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-02
Q4 2015 $4.42M -$6.1M +$14.1M +69.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-03
Q3 2015 -$9.7M $5.01M +$12.6M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-03
Q2 2015 -$22.3M $2.57M +$5.75M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-03
Q1 2015 -$28.1M $2.93M +$3.72M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-03
Q4 2014 -$31.8M -$20.2M +$32.4M +61.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$64.1M -$7.6M -$8.52M -932% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$55.6M -$3.18M -$1.72M -118% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$53.9M -$782K -$1.94M -168% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
Q4 2013 -$52M -$52.6M -$43.1M -452% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-06
Q3 2013 -$8.92M $914K +$18.5M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-06
Q2 2013 -$27.4M -$1.46M +$13M +90% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-06
Q1 2013 -$40.5M $1.16M +$1.74M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-06
Q4 2012 -$42.2M -$9.53M -$10.1M -1892% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-18
Q3 2012 -$32.2M -$17.6M -$19.4M -1085% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-18
Q2 2012 -$12.8M -$14.5M -$16.1M -1022% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-18
Q1 2012 $3.31M -$584K -$791K -383% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-18
Q4 2011 $4.1M $532K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 $1.79M +$870K +95% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 $1.57M +$395K +33.5% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 $207K Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 $916K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $1.18M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.